ID
14822
Description
Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL; ODM derived from: https://clinicaltrials.gov/show/NCT01562977
Link
https://clinicaltrials.gov/show/NCT01562977
Keywords
Versions (1)
- 4/29/16 4/29/16 -
Uploaded on
April 29, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Aggressive Lymphoma NCT01562977
Eligibility Aggressive Lymphoma NCT01562977
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
pregnant or lactation women
Data type
boolean
Alias
- UMLS CUI [1,1]
- C2828358
- UMLS CUI [1,2]
- C0549206
Description
Central nervous system lymphoma
Data type
boolean
Alias
- UMLS CUI [1]
- C0742472
Description
renal or hepatic impairement
Data type
boolean
Alias
- UMLS CUI [1]
- C0948807
- UMLS CUI [2]
- C0948807
Description
hiv positive
Data type
boolean
Alias
- UMLS CUI [1]
- C0019699
Description
psychiatric disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0004936
Description
murine protein
Data type
boolean
Alias
- UMLS CUI [1]
- C1699668
Description
patients who have received more than 2 therapeutic previous lines
Data type
boolean
Alias
- UMLS CUI [1]
- C0868551
Similar models
Eligibility Aggressive Lymphoma NCT01562977
- StudyEvent: Eligibility
C0549206 (UMLS CUI [1,2])
C0948807 (UMLS CUI [2])
No comments